Tomaselli G, Modestin J
Pharmacopsychiatry. 2004 Sep;37(5):236-8. doi: 10.1055/s-2004-832598.
We describe here the occurrence of a serotonin syndrome (SS) in a 64-year-old depressed female patient with alcoholic hepatic cirrhosis after treatment with SSRIs. Two weeks after the increase of the dosage of sertraline, the patient developed a full-blown SS, which resolved completely after the discontinuation of the drug. The therapy with citalopram led again to development of milder SS, this time immediately after the increase of the dosage. Our case illustrates the variability of the clinical presentation and the temporal evolution of SS in a patient with preexisting medical illness affecting hepatic metabolism. Reexposure of patients with a history of SS to another serotoninergic drug should be avoided; if necessary, it must be carried out with the utmost caution.
我们在此描述了一名64岁患有酒精性肝硬化的抑郁症女性患者在使用选择性5-羟色胺再摄取抑制剂(SSRI)治疗后发生血清素综合征(SS)的情况。在舍曲林剂量增加两周后,该患者出现了典型的血清素综合征,停药后完全缓解。使用西酞普兰治疗再次导致较轻的血清素综合征,这次是在剂量增加后立即出现。我们的病例说明了在患有影响肝脏代谢的既往疾病的患者中,血清素综合征临床表现的变异性和时间演变。有血清素综合征病史的患者再次接触另一种血清素能药物应予以避免;如有必要,必须极其谨慎地进行。